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A review was conducted to examine published works that focus on the complex epidemiology of Enterocytozoon bieneusi infection
in humans. Studies on the prevalence of these emerging microsporidian pathogens in humans, in developed and developing
countries, the different clinical spectra of E. bieneusi intestinal infection in children, in different settings, and the risk factors
associated with E. bieneusi infection have been reviewed. This paper also analyses the impact of the recent application of PCR-
based molecular methods for species-specific identification and genotype differentiation has had in increasing the knowledge of
the molecular epidemiology of E. bieneusi in humans. The advances in the epidemiology of E. bieneusi, in the last two decades,
emphasize the importance of epidemiological control and prevention of E. bieneusi infections, from both the veterinary and human
medical perspectives.
1. Introduction
Microsporidia are a group of obligate intracellular eukaryotic
parasites first identified as the cause of pébrine disease
of silkworms in 1857 [1]. Over the past two decades,
microsporidia have risen from obscure organisms to well-
recognized human pathogens. Several genera and species
of microsporidia were found in humans, and diagnosis
and clinical management of microsporidiosis cases have
improved significantly. Despite these scientific advances, the
epidemiology of human microsporidiosis is still unclear.
Most of what is now known about human microsporidiosis
can be attributed to experience with patients infected
with human immunodeficiency virus (HIV). Since 1985
and the first recognition of Enterocytozoon bieneusi as an
acquired immunodeficiency syndrome (AIDS)-associated
opportunistic pathogen [2], several hundred patients
with chronic diarrhea attributed to this organism have
been reported. Cases of intestinal microsporidiosis due
to E. bieneusi have been increasingly reported in other
immunocompromised individuals such as organ transplant
recipients, as well as in travelers, children, and elderly [3–
12]. Hepatobiliary and pulmonary involvement has also
been observed in immunocompromised persons [13–15].
Some reports in humans suggested that this species can
produce asymptomatic infections in immunocompromised
and immunocompetent individuals [16–20]. In addition, E.
bieneusi has been commonly identified in animals, espe-
cially mammals [21–32], and water, raising public health
concerns about zoonotic and waterborne transmission of
microsporidia [33–35].
2. Prevalence of Enterocytozoon bieneusi in
Humans
Enterocytozoon bieneusi infections in humans are mainly
detected by light microscopy of stained fecal smears, electron
microscopy, and PCR-based methods. Therefore, infection
rates are difficult to compare because of the considerable dif-
ferences in the diagnostics methods employed, the specimens
analyzed, the geographical locations, the patient groups, and
patients characteristics (sex, age, socioeconomic conditions,
immune status, and clinical features).
In developed countries in North America, Europe, and
Australia, studies involving HIV-seropositive persons with
diarrhea reported rates between 2% and 78% [17, 36–
45]. Lower infection rates (between 1.4% and 4.3%) were
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reported in HIV-seropositive persons without diarrhea [17,
39, 43, 45]. In one study of HIV-seronegative patients
with diarrhea or pneumonia, spores of E. bieneusi were
detected in 2.5% of urine, 11.5% of fecal, and 16.2%
of sputum samples examined [46]. In majority of the
studies performed in developed countries E. bieneusi was
the species detected most often, followed by E. intestinalis;
nevertheless, these findings are not in accordance with results
of a study performed recently in Czech Republic, involving
immunocompetent humans [20]. In this study, E. bieneusi
was detected four times less frequently than E. cuniculi,
and E. intestinalis was identified only sporadically. Also the
majority of microsporidial infections (reaching 94%) were
reported for nondiarrheal specimens [20]. Recently, a study
was conducted in Portugal. It spans a period between 1999
and 2009, involving 856 patients (561 HIV-seropositive and
295-seronegative) and respective clinical data. The authors
observed that E. bieneusi was more common in the HIV-
seropositive group of patients (7.0%–39) than in the HIV-
seronegative group (5.1%–15) [45].
In developing countries, E. bieneusi prevalence rates were
reported between 2.5% and 51% in HIV-seropositive adult
patients with diarrhea [47–60], and in 4.6% of patients
without diarrhea [55]. Also in developing countries, in
HIV-seronegative persons with and without diarrhea, E.
bieneusi was detected in 5.35% to 58.1% of the fecal samples
examined [19, 51, 53, 54, 61, 62]. In studies conducted
in children, E. bieneusi prevalence ranged from 17.4% to
76.9% in HIV-seropositive children with diarrhea, and from
0.8% to 22.5% in the immunocompetent or apparently
immunocompetent groups of children with or without
diarrhea [18, 19, 30, 49, 63–68]. The recovery of spores
of E. bieneusi in 0.8% of African children considered HIV
seronegative, and in 5.9% of healthy orphans and 1.9%
of child-care workers in Asia, indicated the presence of
enteric carriage of infection in immunocompetent persons
in tropical countries [49, 69]. Table 1 gives an overview of the
studies conducted on the prevalence of E. bieneusi infection
in humans, in various areas.
In industrialized nations, some studies reported E.
bieneusi infection rates between 6.1 and 10% in travelers who
suffered from self-limited diarrhea and returned from tropi-
cal destinations [6, 8]. In addition, a prevalence of 17.0% of
E. bieneusi infection in elderly persons was observed, leading
to the speculation that age-related diminishment of the
immunity might predispose these persons to microsporidial
infections [7].
A few prospective studies conducted in developed coun-
tries indicate that the prevalence of E. bieneusi in HIV-
seropositive patients is progressively decreasing, probably
due to the use of highly active antiretroviral therapy
(HAART) [70, 71]. Similar observations are also made
recently in some developing countries. In a study con-
ducted in Brazil, comparing enteric parasitic infections
in HIV/AIDS patients before and after the HAART, a
statistically significant reduction in the prevalence of these
infections was observed (63.9% versus 24%) [72]. Also in
a 1-year longitudinal study of E. bieneusi infection in the
same orphanage in Bangkok, Thailand, a decreasing pattern
of prevalence, similar to the one observed for the incidence,
was detected [19].
3. Patterns of Enterocytozoon bieneusi
Intestinal Infection in Children
Microsporidia are ubiquitous in nature [73], and so it
should come as no surprise that they can infect humans and
cause clinical disease. E. bieneusi was the first microsporidia
species observed by transmission electron microscopy in
1982 in villus epithelial cells in small intestinal biopsies from
AIDS patients with diarrhea [74]. This species is closely
linked with persistent diarrhea and wasting in adults who
are HIV/AIDS positive; however, the outcome of follow-up
studies involving children who are also HIV/AIDS-positive
and severely malnourished children may be entirely different
and warrants further study.
In the last decade, several studies reported the recovery of
E. bieneusi spores from children’ stools associated to different
clinical spectra (symptomatic and asymptomatic infections
in HIV-seropositive and seronegative children), in different
settings (Table 1).
In immunocompetent or apparently immunocompetent
children, several cases of E. bieneusi infection have been
described. In a study conducted in children considered HIV
seronegative, attending two primary care centers in Niamey,
Niger, E. bieneusi spores were recovered in 8 of 990 stool
samples from these children (six males and two females, with
ages ranging between 3 and 26 months). The methods used
were chromotrope 2R staining and electronic microscopy
for species confirmation. Seven of the E. bieneusi infected
children were symptomatic, and one was asymptomatic.
Three of the symptomatic ones presented other intesti-
nal coinfections with Giardia intestinalis (one), Entamoeba
histolytica (another), and G. intestinalis and Trichomonas
intestinalis (the third child) and complaint of diarrhea. Due
to these associations, the pathogenic role of microsporidia,
in these children, is difficult to ascertain. Although, for the
other four symptomatic children, whose stools were positive
for E. bieneusi, this was the only enteropathogen identified;
two had diarrhea only, one had diarrhea and vomiting, and
the last one complaint of vomiting, dehydration, and fever
without diarrhea [49]. Also a case of dual infection with
E. bieneusi and Cryptosporidium was reported in a healthy
three-year-old Turkish girl (HIV seronegative) living in
Germany that accompanied her family on a vacation trip to
Turkey, where they resided in a rural area. Two months later
the child developed profuse watery, nonbloody diarrhea,
and nausea with recurrent vomiting, weight loss, and seri-
ous dehydration. The diagnosis was performed using light
microscopy and electronic microscopy for microsporidia
species confirmation. The girl’s diarrhea resolved without
treatment after six weeks. As it happens in the above
study the pathogenic role of microsporidia is difficult to
ascertain in this child, due to the concomitant presence of
Cryptosporidium in stools [10]. Another investigation was
carried out to search for microsporidian spores in the stool
specimens of 344 toddlers, essentially HIV seronegative, aged
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Table 1: Studies on prevalence of Enterocytozoon bieneusi infection in humans.
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25.3% (24/95) in HIV+;











2.6% (1/39) in HIV+;
4.4% (11/251) in HIV–
[5]







and 7 patients with
diarrhea.






















Oceania Australia HIV+ Diarrhea Fecal samples LM 3.6% (5/139) [103]
LM: light microscopy, EM: electron microscopy, TEM: transmission electron microscopy, IFAT-MAb: indirect immunofluorescent assay with monoclonal
antibodies, NA: not available, TB: tuberculosis, Pts: patients.
1 to 24 months, and hospitalized at a pediatric institution
in Tucumán, Argentina. They were classified in two groups:
I, made up of 222 children suffering from severe diarrheas,
and II by 122 affected by different pathologies, except
gastroenteritis. The detection of microsporidia was done
by light microscopy in smears of stained stools although
the determination of the species involved was not done.
Coproparasitological and coprobacteriological studies were
also carried out and the nutritional status of each child
was determined. In group I, microsporidia were found in
7.2% (16/222) of the children, 4/68 (5.9%) belonged to
eutrophic children, and 12/137 (8.8%) to undernourished
children; 8/16 positives were found to be related with
other enteropathogenics. In group II, microsporidia were
detected in 8.2% (10/122), 4/47 (8.5%) in eutrophic children,
4/54 (7.4%) in undernourished children, and without data
in two cases; five out of 10 positives were related with
other enteropatogenics. In this study, the occurrence of
intestinal microsporidia was important and did not show
significant differences between toddlers with or without
diarrhea, eutrophic, or undernourished children [63]. An
unusual E. bieneusi genotype (Peru 16), transmitted from
guinea pigs, was found in a 2-year-old immunocompetent
child complaining of diarrhea, in Peru. This child suffered
weight loss that started almost concurrently with the episode
of diarrhea at the beginning of this infection episode. This
finding suggests that this species may cause short-lived
gastrointestinal manifestation in immunocompetent persons
[75]. Also, in a study conducted in Portugal, involving 295
HIV-seronegative patients with gastrointestinal complaints,
of whom 18.6% (55) were children, it was observed that
microsporidians were more common in children 18.2%
(10/55), than in adults 6.3% (15/240), and this difference
was statistically significant (P = 0.012). The age of the
HIV-seronegative children infected ranged from 20 months
to 8 years, with a median of 3 years. The percentage of
infection by E. bieneusi was similar in both age groups,
5.5% for children against 5.0 % for the adults. In the
same study, the overall percentage of HIV-seronegative
patients with diarrhea (4.5%; 7), due to E. bieneusi,
was slightly smaller than that of nondiarrheal (5.7%; 8)
[45].
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Studies have been conducted also in immunocom-
promised children, especially HIV-seropositive ones. In a
prospective study conducted in Madrid, Spain, to deter-
mine the prevalence rates of microsporidiosis and other
enteroparasites in 83 HIV-seropositive children treated in
three hospitals of the city, E. bieneusi was found in 1.2%
(one) of the children. Microsporidia spores were identified
by staining methods and confirmed by PCR. The infected
child was 10 years old and presented nonchronic diarrhea
and a CD4 count of 298/mm3 [66]. In another investigation
carried out in a day care treatment center and the National
Hospital of Niamey, Niger, in HIV-seropositive patients,
before the introduction of highly active antiretroviral therapy
(HAART), one child out of a group of 24 patients, all adults,
was positive for E. bieneusi, by real-time PCR. However,
no other clinical data were provided in the study [76]. A
recent study conducted in, Lisbon, Portugal, involved 126
HIV-seropositive children, in a total of 561 HIV-seropositive
patients with gastrointestinal complaints of whom 18.6%
(55) were children, it was observed that microsporidians
were more common in children 19.0% (24), than in adults
12.4% (54). The percentage of infection by E. bieneusi was
higher in children (10.3 %; 13) than in adults (6.0%; 26), but
this difference was not statistically significant. In the same
study, the overall percentage of HIV-seropositive patients
with diarrhea (8.6%; 29/339), due to E. bieneusi, was lower
than that of nondiarrheal (4.5%; 10/222). Also here the
difference was not statistically significant [45].
Also studies have been carrying out in institutionalized
and inpatient children, independent of the HIV status.
A study was undertaken in Dar es Salaam, Tanzania,
to relate the protozoan infections by Cryptosporidium,
microsporidia, and Cyclospora with the clinical features and
HIV status of children, aged 15–60 months, and adults
hospitalized with diarrhea. Included in the study there were
two groups of inpatient symptomatic children: children
with chronic diarrhea (of whom 23 of 59 were HIV-
seropositive) and children with acute diarrhea (of whom
15 of 55 were HIV seropositive). Microsporidia spores were
identified by staining methods and the species confirmed
by transmission electron microscopy. Enterocytozoon was
identified in specimens from 2/59 children with chronic
diarrhea (one HIV seropositive) and in 0/55 children with
acute diarrhea [77]. Another study designed in Bangkok,
Thailand, investigated the prevalence and clinical features of
intestinal microsporidiosis in hospitalized HIV-seropositive
and seronegative children with diarrhea. Of the 95 HIV-
seropositive and 87 seronegative children, 25.3% (24) and
14.9% (13), respectively, were diagnosed with intestinal
microsporidiosis. Species identification of microsporidia
spores by transmission electron microscopy demonstrated
E. bieneusi in five cases. Cryptosporidium parvum was a
common coinfective parasite. Malnutrition was commoner
in the HIV-seropositive group (79.2% versus 23.1%; P =
0.003). This study indicated that intestinal microsporidiosis
was an important disease in both HIV-seropositive and -
seronegative Thai children with diarrhea [65]. In a cross-
sectional, case-control study, involving children aged <60
months, with undetermined HIV status, undertaken in
Kampala, Uganda, using genetic tools, a total of 17.4% of
1,779 children with diarrhea, attending a hospital, were
infected with E. bieneusi compared with 16.8% of 667
control children (without diarrhea). There was no significant
relationship between infection with E. bieneusi and stunting,
being underweight, wasting, or acute diarrhea. The authors
observed that children with a high rate of excretion of
spores were more likely to have diarrhea of longer duration
(P < 0.001), which they hypothesized could suggest an
association with more prolonged illness. It was concluded
that E. bieneusi was widespread among children 3–36 months
of age in Uganda, and that there was no clear association of
E. bieneusi with poor nutrition or diarrhea [18]. The same
authors, in a following study involving 243 children, aged
<60 months with persistent diarrhea (>14 days), admitted
to the same hospital in Kampala, Uganda, using microscopy
and PCR methods, screened for the presence of E. bieneusi
and Cryptosporidium in the children’ stools [64]. They found
that 32.9% (80) of them were excreting E. bieneusi, and
31.3% (76) were excreting Cryptosporidium. Ninety-one of
the 243 children were HIV seropositive, of whom 76.9%
(70) had E. bieneusi, versus 6.6% (10) of the 152 HIV-
seronegative (odds ratio = 47.33; 95% CI = 19.88 to 115.97),
while 73.6% (67) had Cryptosporidium, versus 5.9% (9)
without HIV (odds ratio = 44.36; 95% CI = 18.39 to 110.40).
Children with counts <25% CD4 cells were more likely to
have either E. bieneusi (odds ratio = 7.42; 95% CI = 3.77
to 14.69) or Cryptosporidium (odds ratio = 6.45; 95% CI
= 3.28 to 12.76) than those with higher CD4 percentages.
However, only HIV status was independently associated
with either E. bieneusi or Cryptosporidium. Among the 243
children with persistent diarrhea, 27.8% (67) were infected
with both enteric pathogens, with HIV being the only
independent predictor of coinfection. Finally, some 81% of
HIV-seropositive children with persistent diarrhea excreted
one or both organisms, compared with only 10% of children
with persistent diarrhea testing negative for HIV. As in their
previous study on E. bieneusi [18] there was no significant
association between infection in this subpopulation and
malnutrition even after controlling for HIV status and CD4
counts/percentages. Once more authors concluded that E.
bieneusi as well as Cryptosporidium were highly prevalent in
Ugandan children, especially those immunocompromised by
HIV/AIDS [64]. Also a study was conducted among hospital
patients and school children in Vhembe district, Limpopo
Province, South Africa, for microsporidia detection using
PCR-RFLP and staining methods. In the age group between
0 and 9 years, E. bieneusi was found in 50 children
(six HIV seropositive) attending the hospital, of whom
80% (40/50) complaint of diarrhea, and in nine school
children (apparently healthy) in the same age group, of
whom 33% (3/9) had diarrhea [54]. In a cross-sectional
study of intestinal microsporidiosis conducted, this time in
Bangkok, Thailand, in children who lived in an orphanage,
stool samples were collected from 290 orphans (39 HIV
seropositive and 251 HIV seronegative). Stool analysis was
made under light microscopy, and confirmation of species
was performed using transmission electron microscopy. Of
the 290 children, 4.1% (12) were positive for E. bieneusi [5].
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Taking into consideration the results obtained in this study,
the same authors conducted a 1-year-longitudinal study of
E. bieneusi infection in the same orphanage. A total of 540
orphans and 81 child-care workers were enrolled in the study.
Using microscopy and PCR methods these authors found
that 13.9% (75) of the orphans had E. bieneusi spores in fecal
samples. Only 28.6% (2/7) of the diarrheic children were
infected by E. bieneusi. In this study E. bieneusi infection was
significantly prevalent in children between 1 and 3 years of
age with a lower incidence in the older age group, which
may reflect the development of protective immunity. Nine
orphans (three HIV seropositive) were reinfected (4-month
intervals between two positive PCRs) in the study. Thus, the
authors hypothesized that protective immunity might not
be fully developed after an infection in some children since
reinfection occurred [19].
Asymptomatic infections with E. bieneusi have been
reported in both HIV-seropositive and -seronegative adults
although in children the asymptomatic cases were described,
so far, only in HIV-seronegative children. In a study per-
formed in Tanzania, in four of 20 HIV-seronegative children
admitted to hospital due to acute trauma or elective surgery,
with no history of diarrhea in the previous 3 months, E.
bieneusi spores were identified by staining methods and the
species confirmed by transmission electron microscopy. All
four asymptomatic children were underweight (P < 0.01). In
the cross-sectional study of parasitic infection conducted in
Bangkok, Thailand, in orphan children, spores of E. bieneusi
were detected in stool specimens, by a staining method and
confirmed by transmission electron microscopy, in 5.9%
(13/221) of the HIV-seronegative children who had neither
current illness nor history of gastrointestinal symptoms
in the previous 1 month [69]. Also in Kampala, Uganda,
E. bieneusi was detected by molecular methods in stool
samples of 112 children, with undetermined HIV status,
without diarrhea [18]. In the study conducted in Limpopo
Province, South Africa, E. bieneusi asymptomatic infections
were detected in 20% (10/50) of the children aged 0 to 9
years, observed in the hospital, and in 67% (6/9) of the
school children enrolled in the study, by PCR methodology
[54]. In another study, in Cameroon, E. bieneusi was, once
more, detected in stools samples from healthy persons
without symptoms, including teenagers (12–19 years old)
and children in the age group between 0 and 11 years. The
percentage of infection increased with age; however, children
had the highest parasite loads [53].
The pathogenicity of microsporidia is still not clearly
defined, and the mechanism by which they induce diarrhea
has not been determined. Some authors found that even
though HIV-positive patients infected by E. bieneusi had
more diarrhea than those noninfected, they in fact had less
inflammation than the noninfected HIV-positive individu-
als, demonstrated by a lactoferrin test, even though some
genotypes of E. bieneusi can cause chronic diarrhea [48, 54].
Enterocytozoon bieneusi can be an important cause of
persistent diarrhea, intestinal malabsorption, and wasting
in HIV-positive adults. Mucosal damage associated with
microsporidiosis is more extensive than that related to other
opportunistic intestinal infections and leads to substantial
malabsorption of vitamins, micronutrients, carbohydrates,
and fats [71, 78, 79]. Although microsporidiosis is common
in children <5 years of age, particularly those who live
in developing countries or who are HIV-seropositive, the
effects of infection on nutritional health of these vulnerable
populations were not well documented until recently [18,
64, 65, 80]. In a study conducted in Uganda, in children
≤60 months of age with persistent diarrhea E. bieneusi was
associated with lower rates of weight gain. This relationship
remained after controlling for HIV and concurrent cryp-
tosporidiosis. Children with microsporidiosis were predicted
to weigh 1.3 kg less than children without microsporidiosis
at 5 years of age [81].
Diarrhea and malabsorption seem to be the most
common clinical problems associated with microsporidian
infections, namely, E. bieneusi, reported in the literature
[14, 46, 82]. However in some studies there were no
statistically significant associations between the presence
of microsporidia, namely E. bieneusi, in faecal specimens
and patients with diarrhea [45, 55, 83–85]. Several studies
suggest that E. bieneusi infection can remain asymptomatic
suggesting that some persons may be asymptomatic carriers
of these microorganisms [19, 49, 69, 77].
4. Risk Factors Associated with
Enterocytozoon bieneusi Infection
Since the identification of E. bieneusi as a pathogen in
humans, it has been shown to be a major cause of chronic
diarrhea in HIV-seropositive persons. Some studies have
tried to identify risk factors for E. bieneusi infection in
humans (Table 2). Immunodeficiency, especially that asso-
ciated with HIV/AIDS, low CD4+ T cells count (≤50 cells
per microliter blood), and younger age are all considered
risk factor for intestinal microsporidiosis due to E. bieneusi
[18, 19, 45, 64, 86, 87]. In Ethiopia, in a study conducted
in 214 HIV-seropositive and 29 HIV-seronegative patients
with diarrhea, microsporidial parasites (E. bieneusi and E.
intestinalis) were detected only in HIV-seropositive patients
(39). Among the patients studied 92.3% had diarrhea for
over four weeks, and 94.9% had weight loss of more than
10% [82]. Also in a recent study performed in Russia, involv-
ing 159 HIV-seropositive patients, a statistically significant
association was observed between the microsporidia positive
patients and weight loss of>10% of the baseline (63%; 19/30)
[87]. In a 10-year study, performed in Portugal, involved
856 (675 adults and 181 children) HIV-seropositive and
-seronegative patients with gastrointestinal complaints, an
immunosuppressive condition and youth (children) were the
risk factors observed for microsporidian infection [45].
Other risk factors associated with intestinal microsporid-
iosis, in general, or particularly to E. bieneusi infection have
been reported. A US study of HIV-seropositive patients
with diarrhea showed significant association of intestinal
microsporidiosis with contact with horses, having been stung
by a bee, hornet, or a wasp, and having used injection drugs.
The use of hot tub or spa and occupational contact with
water also reached statistical significance in this study [86].
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Living in rural areas: contact with animals [50]
Contact with cow dung [50]
Contact with horses [84]
Contacts with duck or chicken droppings [48]
Having been stung by bees, hornets, or wasps [84]
Food: watermelon consumption [48]
Water
Consumption of nonpiped water [50]
Hot tub, spa, and occupational contact with water [86]





Lack of flush toilet [48]
Lack of garbage collection [48]
Lack of running water [48]
Also person-to-person transmission has been suggested in
an orphanage, where a multivariate analysis showed that
orphans who were 12–23 months old, girls, and living in
one particular house were independently associated with E.
bieneusi infection. All infected children presented the same
E. bieneusi genotype in stools [5, 19]. Another study in Zim-
babwe showed association of E. bieneusi infection in HIV-
seropositive patients with living in rural areas, consumption
of nonpiped water, contact with cow dung, and contact
with a person with diarrhea [50]. These authors postulated
the reasons for the unclear association between injection
drug use and enteric microsporidiosis stating that injection
drug users were as likely or more likely to contact potential
infectious sources, such as contaminated water. Contact with
water is an important risk factor consistently associated with
E. bieneusi infection in epidemiologic studies, and E. bieneusi
spores have been detected in ground, surface, ditch, and
crop irrigation water sources [33, 105–107, 132]. However,
no significant seasonal variation has been detected in the
prevalence of intestinal microsporidiosis in HIV-seropositive
patients [70]. In a study of HIV/AIDS patients performed
in Peru, risk factors for E. bieneusi infection differed by
genotype. Infection with genotype Peru-1, one of the more
common genotypes found, was associated with contact with
duck or chicken droppings and lack of running water, flush
toilet, or garbage collection. In contrast, genotypes Peru-2 to
Peru-11 were associated with watermelon consumption [48].
E. bieneusi has been able to cause clinical disease in
immunocompromised and immunocompetent persons with
different patterns, and the risk factors associated with these
pathologies are partially known as a result of improvement
in genetic typing and molecular epidemiology.
5. Molecular Epidemiology of
Enterocytozoon bieneusi in Humans
The combination of epidemiologic studies with genotyping
techniques has contributed to a better understanding of
the characteristics of microsporidia that infect humans
and of its reservoirs and transmission patterns. Before the
introduction of the molecular tools, the characterization
of this important group of parasites relied exclusively on
electron microscopic observations of the morphological
differences in spores and/or endogenous developmental
stages and host occurrence. The recent application of PCR-
based molecular methods for species-specific identification
and genotype differentiation of microsporidia has increased
research interests in this group of microorganisms. The
enhanced diagnostic capacity obtained with the molecular
methods has improved the identification of human cases of
microsporidiosis due to E. bieneusi, not only in developed
countries [6, 7, 17, 20, 30, 38, 45, 62, 66, 81, 87, 92, 108,
112, 115], but also, and especially, in developing countries
where E. bieneusi may be a public health problem due to
the magnitude of the HIV pandemic and poor sanitary
conditions [18, 19, 30, 47, 48, 50–52, 54–56, 62, 64, 68, 88,
89, 99, 102].
Enterocytozoon bieneusi is a complex species with mul-
tiple genotypes and diverse hosts range and pathogenicity.
Since different strains cannot be discriminated morpholog-
ically, typing of this species relies on molecular methods
[22]. PCR analysis of the internal transcribed spacer (ITS)
of the rRNA gene, a hypervariable sequence with about
243 bp long, followed by sequencing of the PCR products
and comparison of obtained ITS sequences with those in the
databases, is the standard method for genotyping E. bieneusi
isolates from humans and animals. For several years these
were the only genetic markers available [22, 56, 104, 133–
136]. A few researchers genotyped E. bieneusi based on
the analysis of the ITS by PCR-restriction fragment length
polymorphism (RFLP) [92, 109]. And recently, two groups of
researchers reported the analysis of the GenBank E. bieneusi
ITS sequence collection, using statistical methods, with the
aim to obtain information about diversity, transmission,
and evolution of this species [135, 136]. These studies have
identified the presence of host-adapted E. bieneusi genotypes
in a variety of domestic animals and wild mammals, as
well as a large group of E. bieneusi genotypes that do not
appear to have host specificity [24, 25, 135, 136]. These
latter genotypes, considered zoonotic, are responsible for
most human infections. E. bieneusi genotypes in humans
have been shown to differ from each other in virulence
and geographic distribution [48, 136]. Other authors, taking
advantage of the current genome sequence surveys of E.
bieneusi, identified four polymorphic microsatellite and
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minisatellite markers. Together with the ITS, they became
part of a multilocus sequence typing (MLST) technique
developed for genotyping E. bieneusi that could be useful
in epidemiologic investigations of E. bieneusi transmission,
especially those concerning the public health significance of
parasites of animal origin [137]. The observations, obtained
with the study of the ITS locus, were also corroborated with
the phylogenetic analysis of the polymorphic microsatellite
and minisatellite markers, identified by Feng and collabo-
rators in the E. bieneusi genome. These authors observed
the formation of two large groups of E. bieneusi: zoonotic
genotypes and host-adapted genotypes [137].
Actually, more than 90 different genotypes of E. bieneusi,
identified by ITS sequence, have been described in humans
and animals, and some genotypes have multiple names
that have been reviewed in Satı́n and Fayer, 2011 [138]
who tabulated all the existing synonyms for the first time
and proposed a standardized nomenclature for E.bieneusi
genotypes based on the ITS sequences. About 34 of these
genotypes have been found only in humans [5, 18, 24, 48, 75,
76, 92, 94, 99, 109, 112, 114, 115] (Table 3), and 11 genotypes
have been reported both in humans and animals [18, 21, 24–
29, 48, 55, 56, 75, 76, 92, 95, 99, 102, 109, 111–114, 116, 118–
127, 129, 139] (Table 4). All these observations were made in
populations from different geographic regions, involving all
continents.
In studies conducted in France involving HIV seropos-
itive and seronegative patients infected with E. bieneusi,
Liguory and collaborators found five genotypes (Types I to
V) [109, 112]. Type I, synonym of genotype B, was the
most prevalent genotype (75%). It was followed by Type
II, designated as genotype C (10%). Genotypes B (Type
I) and C (Type II) were also found in other populations
[94, 95, 99, 111, 112, 115]. Genotype B (Type I) even
showed predisposition toward HIV/AIDS patients [112] and
was the only genotype found in a study performed in
HIV-seropositive patients in Australia [115]. Type IV, also
named genotype K/Peru2/PtEbIII/BEB5/BEB5-var/CMITS1,
was rare (only in one human isolate) [92]. In contrast, Type
IV (genotype K) was the only genotype found in a population
in Cameroon [55]. Moreover, this genotype was also found in
humans in other regions [18, 48, 56, 75, 76, 99, 111, 112] and
in various animals [25–27, 122–125]. Type V was found only
in one HIV-seropositive person.
In Lima, Peru, in a population of 2,672 HIV/AIDS
patients, 11 genotypes were identified (Peru-1 to Peru-
11). The most prevalent genotypes were Peru-1 (39%),
synonym of genotype A, Peru-2 (19%), synonym of Type IV,
and Peru-9 (10%), also named genotype D; the remaining
eight genotypes were found in the population at much
lower frequencies (1–9%) [48, 56, 75]. Some of these
genotypes were also found in animals, including genotype
A (Peru-1), Type IV (Peru-2), Peru-4, also named genotype
EbpC/E/WL13/WL17, to Peru-6, also named PtEb1/PtEbVII,
Peru-7, D (Peru-9), Peru-10 and Peru-11, also named Peru-
12 [21, 24–28, 32, 55, 75, 95, 114, 116, 117, 121–126].
Three genotypes (A/Peru-1, Peru-7, and Peru-11), found
until recently only in humans, were also identified in animals
[32, 117]. Both genotypes D and Type IV (reported as
genotype K) were the most prevalent among patient groups
from Malawi and The Netherlands [112]. Genotype D that
was commonly detected in HIV-seropositive patients was
also found in HIV-seronegative individuals, confirming its
widespread nature [56, 99, 101, 102, 111, 113]. In a study
conducted in renal transplant recipients in Spain, genotype
D was the only E. bieneusi genotype found [108].
Also in Peru, in a prospective pediatric-cohort study
of enteric parasites, E. bieneusi infection was identified in
31 of 388 (8%) children [75]. Thirty of these children
had infections with genotypes Peru-1 (synonym of A)
through Peru-15 and Peru-17, and one child was infected
with genotype Peru-16. Fecal samples of all animals in the
household of child infected with Peru-16 were also analyzed
including guinea pigs, chickens, dogs, and cats. Peru-16
was identified in seven of the eight guinea pigs studied,
and all the other animals were negative for microsporidia.
This genotype was genetically very different from other
known E. bieneusi genotypes in humans and was placed,
in an independent clade, outside the cluster of genotypes
considered to have broad host specificity in a phylogenetic
analysis of the ITS sequences. The finding of genotype
Peru-16 in guinea pigs from unrelated households, and the
close contacts between the study child and infected guinea
pigs, all strongly suggested that the child probably acquired
the infection from the guinea pigs in the household [75].
This finding indicated that even some E. bieneusi genotypes
that are apparently unique in some animals have zoonotic
potential [119]. One of the genotypes, Peru-14, also named
genotype WL15/WL16, was also found in animals [24].
Genotype UG2145, identified for the first time in
Uganda, was the only E. bieneusi detected in a population of
1,779 children with diarrhea [18].
Some genotypes like genotypes B and C are considered
host specific because they were exclusively found in humans.
However, it must be kept in mind that they differ in very few
base pairs from other sequences commonly found in other
hosts. For instance, genotype type IV differs from B in 3 bp,
and from A in just 1 bp. In contrast, some other genotypes
have a zoonotic potential (such as genotypes D and Type IV,
and more recently genotype A) because they have been seen
in various animals [18, 24–27, 29, 48, 75, 76, 95, 111, 112,
116, 118, 119, 122–124, 126, 127, 129, 139].
Breton and collaborators revealed for the first time
the presence of genotypes A and B in Africa [99]. These
genotypes were also reported from HIV-seropositive and
HIV-seronegative populations in Europe [92, 94, 109, 111,
112, 121], Peru [56, 75], Thailand [5, 114], and Niger [76].
In Breton and collaborators study, genotype D was found in
one HIV-seropositive patient in Gabon, and it was identified
for the first time in isolates from three HIV-seronegative
individuals in Cameroon [99]. It is considered a genotype
with a broad host and geographic range, having been found
in several countries in Europe [26, 111, 112, 127], USA
[24, 119], Peru [48, 56, 75], Malawi [112], Thailand [5, 102],
Vietnam [76], and Korea [124, 129]. Three new genotypes
CAF1, CAF2, and CAF3 that are close relatives of genotypes
E, Type IV, and D, respectively, were found for the first
time in the HIV-seropositive patients from Gabon, with
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Table 3: Distribution of Enterocytozoon bieneusi genotypes in humans.
Continent Country Year Patient source Genotype (synonyms)/no. of isolates Reference
Peru 2003 HIV+
A (Peru1)/82, Type IV (K, Peru2, BEB5, BEB5-var, CMITS1, PtEb
III)/41, Peru3/2,
EbpC (E, WL13, Peru4, WL17)/4, WL11 (Peru5)/8, Peru6 (PtEb I,
PtEb VII)/1, Peru7/18, Peru8/10, D (WL8, Peru9, PigEBITS9, PtEb
VI, CEbc)/ 24, Peru10/6, Peru11 (Peru12)/16.
[56]
America Peru 2000–2002 HIV+
A (Peru1)/35, Peru3/1, Peru7/8, Peru8/4, Peru11 (Peru12)/ 6, D
(WL8, Peru9, PigEBITS9, PtEb VI,CEbc)/9, EbpC (E, WL13,
Peru4, WL17)/1, Peru10/3, Type IV (K, Peru2, BEB5, BEB5-var,






A (Peru1), Type IV (K, Peru2), Peru3, EbpC (Peru4),
WL11(Peru5), Peru6 (PtEb I, PtEb VII), Peru7, Peru8, D (WL8,
Peru9, PigEBITS9, PtEb VI, CEbc), Peru10, Peru11 (Peru12),





Type IV (K, Peru2, BEB5, BEB5-var, CMITS1, PtEb III)/18, Peru6
(PtEb I, PtEb VII)/14, D (WL8, Peru9, PigEBITS9, PtEb VI,










B (Type I)/51 HIV+, C (Type II)/6 HIV+, 2 HIV–, Type III/3
HIV+, Type IV (K, Peru2, BEB5, BEB5-var, CMITS1, PtEb III)/3
HIV+
[109]
Europe France 2001 HIV+; HIV−
B (Type I)/66 HIV+, C (Type II)/9 HIV+, 8 immunocompromised
HIV–, and 1 immunocompetent ), Type III/3 HIV+,
Type IV (K, Peru2, BEB5, BEB5-var, CMITS1, PtEb III)/9 HIV+, 2
immunocompromised HIV–,
1 immunocompetent, Type V/1 HIV+
[92]
Germany 1993 HIV+ A(Peru1)/3, B (Type I)/3, C (Type II)/2 [94]
Germany 2001 Human patients C (Type II)/1, Q/1 [95]






B (Type I)/11, D (WL8, Peru9, PigEBITS9, PtEb VI,CEbc)/1, Type





A(Peru1)/1, B (Type I)/4, C (Type II)/5, S7/1, S8/1, S9/1, D (WL8,




2008-2009 HIV− EbpA/10, CZ3/4, PigEBITS5/3, BFRmr2/2, BEB4/2, CZ1/1, CZ2/1 [20]
Russia HIV+ patients D (WL8, Peru9, PigEBITS9, PtEb VI, CEbc)/2 [87]
Niger 2007
HIV+ (227 adults, 1
child)
A (Peru1)/10, D (WL8, Peru9, PigEBITS9, PtEb VI,CEbc)/1, Type






D (WL8, Peru9, PigEBITS9, PtEb VI, CEbc)/2, Type IV (K, Peru2,
BEB5, BEB5-var, CMITS1, PtEb III)/1, new genotype (similar to
genotype K (with two nucleotide substitutions)/1
[67]
Nigeria 2012 HIV+
B/1, new genotype (similar to P, Type IV, UG2145; Peru3, PtEb IV,
PtEb V)/2
[68]
Africa Cameroon 2006 HIV+ Type IV (K, Peru2, BEB5, BEB5-var, CMITS1, PtEb III)/4 [55]
Cameroon 2007
Villagers <1 to 80
years; 0.5% (4/758)
HIV+
A (Peru1)/8, B (Type I)/3, D (WL8, Peru9, PigEBITS9, PtEb VI,
CEbc)/3, Type IV (K, Peru2, BEB5, BEB5-var, CMITS1, PtEb
III)/1, CAF4/5
[99]
Gabon 2007 HIV+ > 16 years
A (Peru1)/1, D (WL8, Peru9, PigEBITS9, PtEb VI, CEbc)/1,






Type IV (K, Peru2, BEB5, BEB5-var, CMITS1, PtEb III)/6,
UG2145/1
[18]
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Table 3: Continued.
Continent Country Year Patient source Genotype (synonyms)/no. of isolates Reference
Africa Malawi 2003-2004
Peru8/1, UG2145/1, S1/2, S2/11, S3/2, S4/1, S5/4, S6/2, D (WL8,
Peru9, PigEBITS9, PtEb VI, CEbc)/4, Type IV (K, Peru2, BEB5,













Asia Thailand 2006 HIV+ (33 adults)
D (WL8, Peru9, PigEBITS9, PtEb VI, CEbc)/12, EbpC (E, WL13,





















T-cell counts < 100
cells mm−3
B (Type I)/29 [115]
10 out of 15 isolates. CAF1 was also found in pigs in Korea
[120]. Another new genotype, CAF4, a highly divergent
genotype reported from humans, was equally present in
HIV-seropositive patients in Gabon and HIV-seronegative
individuals in Cameroon. Its high frequency (25%) in both
countries may indicate that this genotype is common in
Central Africa [99].
Ten Hove and collaborators found nine new genotypes:
six (S1-S6) were from Malawi, and three (S7-S9) were from
The Netherlands [112]. Genotype S7 showed no linkage to
any of the described genotypes and seems to be more related
to the genotypes isolated from cattle. The patient (HIV infec-
tion was considered unlikely) infected with this E. bieneusi
genotype was a middle-age man presenting severe diarrhea
and rectal bleeding. Two other new unnamed genotypes were
detected in this study, AF502396 and AY371283, actually
named as UE2145 and Peru-8, respectively.
In a study conducted in Changchun City, China, involv-
ing 40 fecal samples from diarrheal children and 180 fecal
samples from animals (61 from pigs, 26 from dogs and
93 from cows), all collected in the same area around the
city, Zhang and collaborators found two previously reported
genotypes (genotypes I and J), and 10 new genotypes
(CHN1-10) [30]. Genotypes I (also named BEB2/CEbE) and
J (also named BEB1/CEbB, PtEb X), originally detected in
cattle [25], were identified in both cow and human samples
in this study. Both genotypes coinfected with other genotypes
in all positive samples. Of the novel genotypes, CHN1, which
was detected in five children, nine cows, and four pigs, was
the most common genotype found in this study. Genotype
CHN2 was found only in human samples. Genotypes CHN3
and CHN4 were also found in both human and cow samples,
and genotypes CHN5-10 were only detected in animals.
The ITS sequences of the 10 new genotypes were highly
homologous to those of genotypes I, J, Type IV, and G
published earlier [25, 75, 101, 109, 129]. Genotypes CHN1,
CHN2, and CHN3 differed from J by one to four positions,
while genotype CHN4 is 2 bp shorter than type IV. Due to the
high level of similarity of the sequences, no obvious clusters
related to host preference were observed [30].
In a study that investigated the occurrence and preva-
lences of the microsporidial species Enterocytozoon bieneusi
and Encephalitozoon spp. in 382 immunocompetent humans
in the Czech Republic the sequence analyses of E. bieneusi-
positive samples revealed seven different genotypes [20].
For the first time, after so many studies performed in
humans, in different geographic areas, genotypes that were
previously reported only from cattle (BEB4 and EbpA) and
pigs (PigEBITS5, EbpA, and BFRmr2) were identified in
humans, and three new genotypes were detected (E. bieneusi
CZ1 to CZ3). The most prevalent E. bieneusi genotypes
were EbpA (in 10 individuals), CZ3 (in 4 individuals),
and PigEBITS5 (in three individuals), followed by BFRmr2
and BEB4 (each in two individuals). The CZ1 and CZ2
genotypes were identified only in single individuals. In
the same study E. cuniculi genotype II was also found in
humans. These data suggest that isolates of this group are
able to switch hosts from animals to humans and should be
regarded as isolates with high zoonotic potential. The high
prevalences of microsporidia infection surprisingly found in
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Table 4: Enterocytozoon bieneusi zoonotic genotypes.
Genotype designation Hosts Reference(s)
A Humans, baboons and birds.
[19, 48, 56, 75,
76, 94, 99, 112–
114, 116, 117]
D (PigITS9, WL8, Peru9, PtEbVI, CEbC)
Humans, macaque, baboons, pigs, cattle, horse,
dogs, fox, raccoon, beaver, muskrat, and falcons
[24, 26, 29, 56,




CAF1 (PebE) Humans and pigs. [76, 99, 120]
EbpC (E,WL13, WL17, Peru4)
Humans, pigs, beaver, otter, muskrat, raccoon,
and fox.
[2, 21, 24, 28,
48, 56, 75, 76,
110, 113, 114,
116, 121]
Peru16 Humans and guinea pigs [75]
Peru10 Humans and cats [48, 56, 75, 122]
Type IV ( K, Peru2, PtEbIII, BEB5, BEB5-var)
Humans, cattle, cats, and dogs.
[18, 25–
27, 48, 55, 56,
75, 76, 92, 95,
99, 109, 111,
112, 122–124]
WL11 (Peru5) Humans, dogs, fox, and cats
[24, 48, 56, 75,
122, 123]
O Humans and pigs.
[28, 95, 113,
114]
PigEBITS7 Humans and pigs. [113, 119]
Peru6 (PtEbI, PtEbVII) Humans, cattle, dogs, and birds
[26, 45, 48, 56,
75, 125, 126]
WL15 (WL16, Peru14) Humans, beaver, fox, muskrat, and raccoon [24, 56, 75]
EbpA (F) Humans, cattle, pig, and birds
[20, 28, 95, 116,
119, 121, 127,
128]
I (BEB2, CebE) Humans and cattle
[25, 30, 95, 124,
126, 128–130]
J (BEB1, CebB, PtEb X) Humans, cattle, and birds
[25, 26, 30, 95,
124, 126, 128–
131]
Peru7 Humans and baboons [48, 56, 75, 117]
Peru11 (Peru12) Humans and baboons
[48, 56, 75, 113,
117]
BEB4 Humans and cattle.
[20, 25, 29, 126,
130]
PigITS5 (PebA) Humans and pigs.
[20, 116, 119,
120]
BFRmr2 Humans and pigs. [20, 28]
CHN1 Humans, cattle and pigs. [30]
CHN3 Humans and cattle [30]
CHN4 Humans and cattle [30]
PtEb II Humans and birds [45, 125]
different populations of immunocompetent humans in this
study raise the question of whether these findings represent
true infection resulting in shedding of parasites or ingested
parasites that just passed through the gastrointestinal tract
without establishing an infection. However, the chance of
detecting the temporary passage of spores is quite low in the
number of individuals sampled analyzed in this study [20].
Several studies indicate that the distribution of genotypes
of E. bieneusi can vary by geographical locations [95], and
it has been recently proposed that predominant genotypes
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in different geographical sites could be related to distinct
sources of transmission [5]. In a comparative study of the
molecular epidemiology of microsporidiosis among HIV-
seropositive patients in two separate geographical areas,
Niamey, Niger and Hanoi, Vietnam, interesting results were
obtained. In Hanoi, two zoonotic genotypes D and E
were identified [76]. Both genotypes have been previously
recovered in both humans and animals [21, 24, 26, 56]. These
genotypes were also predominant in a study conducted in
Thailand in HIV-seropositive patients [113]. Thus, there is
a potential zoonotic transmission of E. bieneusi in Thailand
and Vietnam. Zoonotic transmission can be from direct
exposure to animals or by contamination of surface water by
discharged domestic wastewater or animals. On the contrary,
the Niamey data highlighted a higher frequency of genotypes
known to be human specific (genotype A), similar to results
obtained in children from an orphanage in Thailand [5].
These results suggest that transmission of microsporidiosis
due to some E. bieneusi genotypes could occur through
person-to-person contact. This mode of transmission could
be facilitated by chronic carriage of E. bieneusi, as described
in previous studies [49, 140].
All these findings suggest different transmission modes
of E. bieneusi in diverse geographic regions and in special
groups in the same region. However, further studies with
larger number of E. bieneusi samples are needed to confirm
these findings.
6. Conclusion
Despite recent advances in the understanding and diagnosis
of E. bieneusi, emerging microsporidian pathogens, more
research is necessary to elucidate their complex epidemi-
ology. In fact, studies that reflect true human infecting E.
bieneusi prevalence are still insufficient. A few prospective
studies conducted in developed countries indicate that the
prevalence of E. bieneusi in HIV-seropositive patients is
progressively decreasing, probably due to the use of HAART.
Similar observations have also been made recently in some
developing countries. The recovery of spores of E. bieneusi in
fecal samples of children considered HIV-seronegative, and
in healthy ones, indicated the presence of enteric carriage
of infection in immunocompetent persons in tropical coun-
tries, but also in other regions of the globe. Also, the finding
of asymptomatic chronic carriers of E. bieneusi emphasizes
their importance in the transmission cycle, warning for the
potential risk of reactivation of latent infection in cases of
immunosuppression causing life-threatening disease in these
individuals.
The pathogenicity of microsporidia is still not clearly
defined, and the mechanism by which they induce diarrhea
has not been determined. Even though some genotypes of E.
bieneusi can cause chronic diarrhea and wasting syndrome
in AIDS patients once the CD4+ T-lymphocyte count drops
below 100 cells/mm3.
The recent application of PCR-based molecular methods
to E. bieneusi identification and characterization has led to
more reliable results compared with prevalence rates deter-
mined by light microscopy of stained biological smears, to
better study the risk factors associated with these pathologies,
to study the distribution of genotypes of E. bieneusi by
geographical location, to improve source tracking, and to
calculate the host range and pathogenic potential of an
isolate. All typing studies performed until now were based
on the analysis of the ITS sequences, the only molecular
marker existent until recently. These studies identified the
presence of host-adapted E. bieneusi genotypes in several
animals, and E. bieneusi genotypes with no host specificity,
which are considered zoonotic. These zoonotic genotypes
are responsible for most human infections. Some studies
suggest that transmission of microsporidiosis due to some
E. bieneusi genotypes could occur through person-to-person
contact. This mode of transmission could be facilitated by
chronic carriage of E. bieneusi, as described in some studies.
Besides, several microsporidian species that infect humans
have been identified in animals, especially mammals, raising
public health concerns about zoonotic and waterborne
transmission of microsporidia. In addition, some studies
indicate that even some E. bieneusi genotypes, which are
apparently unique in some animals, have zoonotic potential.
Other studies indicate that the distribution of genotypes of
E. bieneusi can vary by geographical locations and virulence.
Despite of the great genetic variation of E. bieneusi
observed worldwide with the analyses of the ITS region of the
rRNA gene, studies with additional independent markers for
E. bieneusi are highly desirable in order to clarify the genetic
structure of the parasite’s populations. The discrimination
among strains of E. bieneusi is very important, not only for
the clarification of the reservoirs and of the transmission
modes of this pathogen but also to help to explain its
variations in pathogenicity that cannot be answered with the
study of a single locus.
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parasites in Cuban acquired immunodeficiency syndrome
(AIDS) patients,” Acta Tropica, vol. 72, no. 1, pp. 125–130,
1999.
18 Journal of Parasitology Research
[91] E. Bernard, M. Carles, C. Pradier et al., “Chronic diarrhoea
in HIV+ patients: role of Enterocytozoon bieneusi,” Presse
Medicale, vol. 24, no. 14, pp. 671–674, 1995.
[92] O. Liguory, C. Sarfati, F. Derouin, and J. M. Molina, “Evi-
dence of different Enterocytozoon bieneusi genotypes in
patients with and without human immunodeficiency virus
infection,” Journal of Clinical Microbiology, vol. 39, no. 7, pp.
2672–2674, 2001.
[93] C. Franzen, A. Müller, P. Hegener et al., “Polymerase chain
reaction for microsporidian DNA in gastrointestinal biopsy
specimens of HIV-infected patients,” AIDS, vol. 10, no. 8, pp.
F23–F27, 1996.
[94] H. Rinder, S. Katzwinkel-Wladarsch, and T. Löscher, “Evi-
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